Use of tigecycline in pediatric clinical practice
MV Mastrolia, L Galli, M De Martino… - Expert Review of Anti …, 2017 - Taylor & Francis
Introduction: Tigecycline, a derivative of minocycline, is an extended-spectrum antimicrobial
agent. It has a restricted approval field in children and the experience of its adoption in …
agent. It has a restricted approval field in children and the experience of its adoption in …
Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with iv ceftazidime–avibactam and …
N Gofman, K To, M Whitman… - The Bulletin of the …, 2018 - academic.oup.com
Purpose A patient with carbapenem-resistant Klebsiella pneumoniae infection is described,
and treatment options are discussed. Summary Few antibiotics to treat carbapenem …
and treatment options are discussed. Summary Few antibiotics to treat carbapenem …
Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A …
H Xing, C Cheng, Y Zhang, Y Cai, X Wang… - Frontiers in …, 2021 - frontiersin.org
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-
resistant (XDR) Acinetobacter baumannii is a life-threatening complication in neurosurgery …
resistant (XDR) Acinetobacter baumannii is a life-threatening complication in neurosurgery …
The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant Klebsiella pneumonia
Y Chen, L Liu - British journal of neurosurgery, 2023 - Taylor & Francis
We report the fourth case of Carbapenem-resistant Klebsiella pneumoniae (CRKP)
meningitis and the only one associated with brain abscess formation. A 29-years-old male …
meningitis and the only one associated with brain abscess formation. A 29-years-old male …
[HTML][HTML] Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report
J Li, Y Liu, G Wu, H Wang, X Xu - Medicine, 2022 - journals.lww.com
Interventions: On the advice of a clinical pharmacist, the patient was given tigecycline (100
mg IV+ 3 mg IVT q12h) combined with amikacin (0.8 g IV+ 30 mg IVT qd) antiinfective …
mg IV+ 3 mg IVT q12h) combined with amikacin (0.8 g IV+ 30 mg IVT qd) antiinfective …
Intraventricular plus intravenous tigecycline for the treatment of daptomycin nonsusceptible vancomycin-resistant enterococci in an infant with ventriculoperitoneal …
A Şahin, N Dalgic - World Neurosurgery, 2019 - Elsevier
Background Ventriculoperitoneal (VP) shunt infection, which is 1 of the most important
complications of VP shunt is observed at a rate of 4%–17%. Staphylococcus epidermidis is …
complications of VP shunt is observed at a rate of 4%–17%. Staphylococcus epidermidis is …
Intraventricular tigecycline for the treatment of shunt infection: a case in pediatrics
B Curebal, N Dalgic, B Bayraktar - Journal of Neurosurgery: Pediatrics, 2018 - thejns.org
Ventriculoperitoneal (VP) shunt infections are seen in 3%–17% of patients with VP shunts.
These infections may cause severe morbidity and mortality. Staphylococci are the most …
These infections may cause severe morbidity and mortality. Staphylococci are the most …
Preliminary experience with tigecycline treatment for severe infection in children
S Ye, C Zhang, S Lin - European journal of pediatrics, 2018 - Springer
Severe infection is a primary cause of mortality in children facing challenges from multidrug-
resistant (MDR) pathogens, particularly MDR Acinetobacter baumannii. Tigecycline has an …
resistant (MDR) pathogens, particularly MDR Acinetobacter baumannii. Tigecycline has an …
[HTML][HTML] Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery
Y Song, L Hu, Q Shu, J Ye, J Liang, X Chen… - International Journal of …, 2018 - Elsevier
Objective The aim of this study was to evaluate the efficacy and safety of salvage therapy of
tigecycline in critically ill children with infections caused by multidrug-resistant …
tigecycline in critically ill children with infections caused by multidrug-resistant …
The identification of risk factors and outcomes of cerebrospinal fluid shunt infections caused by carbapenem-resistant gram-negative bacteria in children: a …
OBJECTIVE Cerebrospinal fluid (CSF) shunt infections caused by gram-negative bacteria
are difficult to treat given the limited treatment options and the emergence of carbapenem …
are difficult to treat given the limited treatment options and the emergence of carbapenem …